Global Depression Therapy & Treatment Market – Insights, Analysis, Shares & Forecast (2017-2023) – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global
Depression Therapy & Treatment Market Insights, Opportunity Analysis,
Market Shares and Forecast 2017 – 2023”
report to their
offering.

Depression treatment market is segmented on the basis of antidepressants
drugs, devices and therapies. Antidepressants are the largest market
segment. Antidepressants are the most popular treatment methods. Every
year more than five billion prescriptions are written globally.
Antidepressants segment consists of big pharmaceuticals companies like
Eli Lily, Pfizer, GlaxoSmithKline and Forest Laboratories. All these
companies are branded drug manufacturers.

Key Companies Profiled:

  • Pfizer
  • GlaxoSmithKline
  • Forest Laboratories
  • Abbot Laboratories
  • Eli Lilly and Company
  • Merck Sharp &Dohme
  • Sanofi
  • Teva Pharmaceuticals Industries
  • Mayo Clinic
  • Sun Pharmaceuticals
  • Brainsway
  • Fisher Wallace
  • MagVentures
  • Lundbeck
  • BoehringerIngelheim GmbH
  • Roche Holding AG

Key Topics Covered:

1. Executive Summary

2. Market Overview -Depression Is A Major Concern Worldwide

3. Market Segmentation

4. Depression Prevalence by Gender

5. Resurgent Generic Drugs market due to patent expiry

6. Competitive Trends, Strategies & Market Share

7. Geographical analysis

8. Corporate profiling

For more information about this report visit http://www.researchandmarkets.com/research/rlv4br/global_depression

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Mental
Disorders Drugs